LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 45

Search options

  1. Article: Severe Perinatal Presentations of Günther's Disease: Series of 20 Cases and Perspectives.

    Goudet, Claire / Ged, Cécile / Petit, Audrey / Desage, Chloe / Mahe, Perrine / Salhi, Aicha / Harzallah, Ines / Blouin, Jean-Marc / Mercie, Patrick / Schmitt, Caroline / Poli, Antoine / Gouya, Laurent / Barlogis, Vincent / Richard, Emmanuel

    Life (Basel, Switzerland)

    2024  Volume 14, Issue 1

    Abstract: 1) Background: Congenital erythropoietic porphyria (CEP), named Günther's disease, is a rare recessive type of porphyria, resulting from deficient uroporphyrinogen III synthase (UROS), the fourth enzyme of heme biosynthesis. The phenotype ranges from ... ...

    Abstract (1) Background: Congenital erythropoietic porphyria (CEP), named Günther's disease, is a rare recessive type of porphyria, resulting from deficient uroporphyrinogen III synthase (UROS), the fourth enzyme of heme biosynthesis. The phenotype ranges from extremely severe perinatal onset, with life-threatening hemolytic anaemia, to mild or moderate cutaneous involvement in late-onset forms. This work reviewed the perinatal CEP cases recorded in France in order to analyse their various presentations and evolution. (2) Methods: Clinical and biological data were retrospectively collected through medical and published records. (3) Results: Twenty CEP cases, who presented with severe manifestations during perinatal period, were classified according to the main course of the disease: antenatal features, acute neonatal distress and postnatal diagnosis. Antenatal symptoms (seven patients) were mainly hydrops fetalis, hepatosplenomegaly, anemia, and malformations. Six of them died prematurely. Five babies showed acute neonatal distress, associated with severe anemia, thrombocytopenia, hepatosplenomegaly, liver dysfunction, and marked photosensitivity leading to diagnosis. The only two neonates who survived underwent hematopoietic stem cell transplantation (HSCT). Common features in post-natal diagnosis (eight patients) included hemolytic anemia, splenomegaly, skin sensitivity, and discoloured teeth and urine. All patients underwent HSCT, with success for six of them, but with fatal complications in two patients. The frequency of the missense variant named C73R is striking in antenatal and neonatal presentations, with 9/12 and 7/8 independent alleles, respectively. (4) Conclusions: The most recent cases in this series are remarkable, as they had a less fatal outcome than expected. Regular transfusions from the intrauterine period and early access to HSCT are the main objectives.
    Language English
    Publishing date 2024-01-17
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662250-6
    ISSN 2075-1729
    ISSN 2075-1729
    DOI 10.3390/life14010130
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Efficacy of pembrolizumab in a patient with xeroderma pigmentosum variant and advanced cutaneous squamous-cell carcinoma.

    Hennemann, Aymeric / Collonge Rame, Marie Agnès / Puzenat, Eve / Ged, Cécile / Harbon, Sylvain / Aubin, François / Nardin, Charlée

    Acta oncologica (Stockholm, Sweden)

    2022  Volume 61, Issue 9, Page(s) 1140–1142

    MeSH term(s) Humans ; Xeroderma Pigmentosum/complications ; Xeroderma Pigmentosum/drug therapy ; Xeroderma Pigmentosum/genetics ; Skin Neoplasms/complications ; Skin Neoplasms/drug therapy ; Skin Neoplasms/genetics ; Carcinoma, Squamous Cell/complications ; Carcinoma, Squamous Cell/drug therapy ; Carcinoma, Squamous Cell/pathology ; Antibodies, Monoclonal, Humanized/therapeutic use
    Chemical Substances pembrolizumab (DPT0O3T46P) ; Antibodies, Monoclonal, Humanized
    Language English
    Publishing date 2022-08-11
    Publishing country England
    Document type Letter
    ZDB-ID 896449-x
    ISSN 1651-226X ; 0349-652X ; 0284-186X ; 1100-1704
    ISSN (online) 1651-226X
    ISSN 0349-652X ; 0284-186X ; 1100-1704
    DOI 10.1080/0284186X.2022.2109425
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Homozygosity for the hyperunstable hemoglobin variant Hb Agrinio (HBA2:c.89T>C) leads to severe antenatal anemia: Eight new cases in three families.

    Szepetowski, Sarah / Berger, Claire / Joly, Philippe / Baron-Joly, Sandrine / Huguenin, Yoann / Cantais, Aurélie / Brun, Sophie / Ged, Cécile / Badens, Catherine / Thuret, Isabelle / Giansily-Blaizot, Muriel / Pissard, Serge / Aguilar-Martinez, Patricia

    American journal of hematology

    2022  Volume 97, Issue 11, Page(s) E393–E395

    MeSH term(s) Anemia/genetics ; Female ; Hemoglobins, Abnormal/genetics ; Homozygote ; Humans ; Pregnancy ; alpha-Thalassemia
    Chemical Substances Hemoglobins, Abnormal ; hemoglobin Agrinio
    Language English
    Publishing date 2022-09-02
    Publishing country United States
    Document type Case Reports ; Letter
    ZDB-ID 196767-8
    ISSN 1096-8652 ; 0361-8609
    ISSN (online) 1096-8652
    ISSN 0361-8609
    DOI 10.1002/ajh.26687
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Phenotypic and genotypic characterization of familial hypercholesterolemia in French adult and pediatric populations.

    Fourgeaud, Mélanie / Lebreton, Louis / Belabbas, Khaldia / Di Filippo, Mathilde / Rigalleau, Vincent / Couffinhal, Thierry / Pucheu, Yann / Barat, Pascal / Ged, Cécile / Bérard, Annie M

    Journal of clinical lipidology

    2022  Volume 16, Issue 3, Page(s) 298–305

    Abstract: Background: Familial hypercholesterolemia (FH) is the most common genetic disorder associated with a high risk for premature atherosclerotic cardiovascular disease attributable to increased levels of LDL-cholesterol (LDL-C) from birth. FH is both ... ...

    Abstract Background: Familial hypercholesterolemia (FH) is the most common genetic disorder associated with a high risk for premature atherosclerotic cardiovascular disease attributable to increased levels of LDL-cholesterol (LDL-C) from birth. FH is both underdiagnosed and undertreated.
    Objective: We describe the clinical, biological, and genetic characteristics of 147 patients in France with clinical FH (including a group of 26 subjects aged < 20 years); we explore how best to detect patients with monogenic FH.
    Methods: We retrospectively reviewed all available data on patients undergoing genetic tests for FH from 2009 to 2019. FH diagnoses were based on the Dutch Lipid Clinics Network (DLCN) scores of adults, and elevated LDL-C levels in subjects < 20 years of age. We evaluated LDLR, APOB, and PCSK9 status.
    Results: The mutations of adults (in 25.6% of all adults) were associated with DLCN scores indicating "possible FH," "probable FH, and "definitive FH" at rates of 4%, 16%, and 53%, respectively. The areas under the ROC curves of the DLCN score and the maximum LDL-C level did not differ (p = 0.32). We found that the pediatric group evidenced more monogenic etiologies (77%, increasing to 91% when an elevated LDL-C level was combined with a family history of hypercholesterolemia and/or premature coronary artery disease).
    Conclusion: Diagnosis of monogenic FH may be optimized by screening children in terms of their LDL-C levels, associated with reverse-cascade screening of relatives when the children serve as index cases.
    MeSH term(s) Adult ; Child ; Cholesterol, LDL ; Humans ; Hyperlipoproteinemia Type II/diagnosis ; Hyperlipoproteinemia Type II/epidemiology ; Hyperlipoproteinemia Type II/genetics ; Proprotein Convertase 9/genetics ; Retrospective Studies ; Young Adult
    Chemical Substances Cholesterol, LDL ; PCSK9 protein, human (EC 3.4.21.-) ; Proprotein Convertase 9 (EC 3.4.21.-)
    Language English
    Publishing date 2022-03-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2365061-8
    ISSN 1876-4789 ; 1933-2874
    ISSN (online) 1876-4789
    ISSN 1933-2874
    DOI 10.1016/j.jacl.2022.03.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Acquired glucose 6-phosphate dehydrogenase (G6PD) deficiency in a patient with Chronic Myelomonocytic Leukemia.

    Naville, Anne-Sophie / Lazaro, Estibaliz / Boutin, Julian / Prot-Leurent, Camille / Mansier, Olivier / Richard, Emmanuel / Augis, Vanessa / Weinmann, Laurent / Fuster, Valerie / Vial, Jean-Philippe / Ged, Cecile / Dulucq, Stephanie

    British journal of haematology

    2022  Volume 197, Issue 4, Page(s) e45–e48

    MeSH term(s) Erythrocytes ; Glucose ; Glucosephosphate Dehydrogenase ; Glucosephosphate Dehydrogenase Deficiency/complications ; Glucosephosphate Dehydrogenase Deficiency/genetics ; Humans ; Leukemia, Myelomonocytic, Chronic/complications ; Leukemia, Myelomonocytic, Juvenile ; Oxidoreductases ; Phosphates
    Chemical Substances Phosphates ; Oxidoreductases (EC 1.-) ; Glucosephosphate Dehydrogenase (EC 1.1.1.49) ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2022-01-06
    Publishing country England
    Document type Letter
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/bjh.18037
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Identification of novel

    Blouin, Jean-Marc / Ged, Cécile / Bernardo-Seisdedos, Ganeko / Cabantous, Txomin / Pinson, Benoît / Poli, Antoine / Puy, Hervé / Millet, Oscar / Gouya, Laurent / Morice-Picard, Fanny / Richard, Emmanuel

    Molecular genetics and metabolism reports

    2021  Volume 27, Page(s) 100722

    Abstract: Congenital erythropoietic porphyria (CEP) is an autosomal recessive disorder of the heme biosynthetic pathway that is characterized by uroporphyrinogen III synthase (UROS) deficiency and the accumulation of non-physiological isomer I porphyrins. These ... ...

    Abstract Congenital erythropoietic porphyria (CEP) is an autosomal recessive disorder of the heme biosynthetic pathway that is characterized by uroporphyrinogen III synthase (UROS) deficiency and the accumulation of non-physiological isomer I porphyrins. These phototoxic metabolites predominantly produced by the erythron result in ineffective erythropoiesis, chronic hemolysis and splenomegaly, but they also disseminate in tissues causing bullous photosensitivity to UV light and skin fragility that may progress to scarring with photo mutilation. Therapeutic management is currently limited to supportive care and bone marrow transplantation is reserved for the most severe cases. We describe here a 26-year-old women previously diagnosed with CEP harbouring two novel
    Language English
    Publishing date 2021-02-11
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2821908-9
    ISSN 2214-4269
    ISSN 2214-4269
    DOI 10.1016/j.ymgmr.2021.100722
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Pigmentation abnormalities in nucleotide excision repair disorders: Evidence and hypotheses.

    Kasraian, Zeinab / Trompezinski, Sandra / Cario-André, Muriel / Morice-Picard, Fanny / Ged, Cécile / Jullie, Marie-Laure / Taieb, Alain / Rezvani, Hamid Reza

    Pigment cell & melanoma research

    2018  Volume 32, Issue 1, Page(s) 25–40

    Abstract: Skin pigmentation abnormalities are manifested in several disorders associated with deficient DNA repair mechanisms such as nucleotide excision repair (NER) and double-strand break (DSB) diseases, a topic that has not received much attention up to now. ... ...

    Abstract Skin pigmentation abnormalities are manifested in several disorders associated with deficient DNA repair mechanisms such as nucleotide excision repair (NER) and double-strand break (DSB) diseases, a topic that has not received much attention up to now. Hereditary disorders associated with defective DNA repair are valuable models for understanding mechanisms that lead to hypo- and hyperpigmentation. Owing to the UV-associated nature of abnormal pigmentary manifestations, the outcome of the activated DNA damage response (DDR) network could be the effector signal for alterations in pigmentation, ultimately manifesting as pigmentary abnormalities in repair-deficient disorders. In this review, the role of the DDR network in the manifestation of pigmentary abnormalities in NER and DSB disorders is discussed with a special emphasis on NER disorders.
    MeSH term(s) Animals ; DNA Damage ; DNA Repair ; Humans ; Models, Biological ; Phenotype ; Pigmentation Disorders/pathology ; Pigmentation Disorders/physiopathology
    Language English
    Publishing date 2018-07-13
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2409570-9
    ISSN 1755-148X ; 1600-0749 ; 0893-5785 ; 1755-1471
    ISSN (online) 1755-148X ; 1600-0749
    ISSN 0893-5785 ; 1755-1471
    DOI 10.1111/pcmr.12720
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Xeroderma Pigmentosum C (XPC) Mutations in Primary Fibroblasts Impair Base Excision Repair Pathway and Increase Oxidative DNA Damage.

    Fayyad, Nour / Kobaisi, Farah / Beal, David / Mahfouf, Walid / Ged, Cécile / Morice-Picard, Fanny / Fayyad-Kazan, Mohammad / Fayyad-Kazan, Hussein / Badran, Bassam / Rezvani, Hamid R / Rachidi, Walid

    Frontiers in genetics

    2020  Volume 11, Page(s) 561687

    Abstract: Xeroderma Pigmentosum C (XPC) is a multi-functional protein that is involved not only in the repair of bulky lesions, post-irradiation, via nucleotide excision repair (NER) ...

    Abstract Xeroderma Pigmentosum C (XPC) is a multi-functional protein that is involved not only in the repair of bulky lesions, post-irradiation, via nucleotide excision repair (NER)
    Language English
    Publishing date 2020-11-27
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2606823-0
    ISSN 1664-8021
    ISSN 1664-8021
    DOI 10.3389/fgene.2020.561687
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria.

    Blouin, Jean-Marc / Ged, Cécile / Lalanne, Magalie / Lamrissi-Garcia, Isabelle / Morice-Picard, Fanny / Costet, Pierre / Daher, Raêd / Moreau-Gaudry, François / Bedel, Aurélie / Puy, Hervé / Gouya, Laurent / Karim, Zoubida / Richard, Emmanuel

    Blood

    2020  Volume 136, Issue 21, Page(s) 2457–2468

    Abstract: Congenital erythropoietic porphyria (CEP) is an inborn error of heme synthesis resulting from uroporphyrinogen III synthase (UROS) deficiency and the accumulation of nonphysiological porphyrin isomer I metabolites. Clinical features are heterogeneous ... ...

    Abstract Congenital erythropoietic porphyria (CEP) is an inborn error of heme synthesis resulting from uroporphyrinogen III synthase (UROS) deficiency and the accumulation of nonphysiological porphyrin isomer I metabolites. Clinical features are heterogeneous among patients with CEP but usually combine skin photosensitivity and chronic hemolytic anemia, the severity of which is related to porphyrin overload. Therapeutic options include symptomatic strategies only and are unsatisfactory. One promising approach to treating CEP is to reduce the erythroid production of porphyrins through substrate reduction therapy by inhibiting 5-aminolevulinate synthase 2 (ALAS2), the first and rate-limiting enzyme in the heme biosynthetic pathway. We efficiently reduced porphyrin accumulation after RNA interference-mediated downregulation of ALAS2 in human erythroid cellular models of CEP disease. Taking advantage of the physiological iron-dependent posttranscriptional regulation of ALAS2, we evaluated whether iron chelation with deferiprone could decrease ALAS2 expression and subsequent porphyrin production in vitro and in vivo in a CEP murine model. Treatment with deferiprone of UROS-deficient erythroid cell lines and peripheral blood CD34+-derived erythroid cultures from a patient with CEP inhibited iron-dependent protein ALAS2 and iron-responsive element-binding protein 2 expression and reduced porphyrin production. Furthermore, porphyrin accumulation progressively decreased in red blood cells and urine, and skin photosensitivity in CEP mice treated with deferiprone (1 or 3 mg/mL in drinking water) for 26 weeks was reversed. Hemolysis and iron overload improved upon iron chelation with full correction of anemia in CEP mice treated at the highest dose of deferiprone. Our findings highlight, in both mouse and human models, the therapeutic potential of iron restriction to modulate the phenotype in CEP.
    MeSH term(s) 5-Aminolevulinate Synthetase/antagonists & inhibitors ; 5-Aminolevulinate Synthetase/biosynthesis ; 5-Aminolevulinate Synthetase/genetics ; Adult ; Anemia, Hemolytic/drug therapy ; Anemia, Hemolytic/etiology ; Animals ; CRISPR-Cas Systems ; Cell Line ; Cell Line, Tumor ; Deferiprone/therapeutic use ; Disease Models, Animal ; Erythroid Cells/drug effects ; Erythroid Cells/metabolism ; Female ; Gene Knock-In Techniques ; Humans ; Iron/metabolism ; Iron Chelating Agents/therapeutic use ; Iron Overload/drug therapy ; Iron Overload/etiology ; Leukemia, Erythroblastic, Acute/pathology ; Mice ; Peripheral Blood Stem Cells/drug effects ; Peripheral Blood Stem Cells/metabolism ; Photosensitivity Disorders/drug therapy ; Photosensitivity Disorders/etiology ; Porphyria, Acute Intermittent/metabolism ; Porphyria, Erythropoietic/complications ; Porphyria, Erythropoietic/drug therapy ; Porphyrins/biosynthesis ; RNA Interference ; RNA, Small Interfering/pharmacology
    Chemical Substances Iron Chelating Agents ; Porphyrins ; RNA, Small Interfering ; Deferiprone (2BTY8KH53L) ; Iron (E1UOL152H7) ; 5-Aminolevulinate Synthetase (EC 2.3.1.37) ; ALAS2 protein, human (EC 2.3.1.37) ; ALAS2 protein, mouse (EC 2.3.1.37)
    Language English
    Publishing date 2020-07-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood.2020006037
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria.

    Mirmiran, Arienne / Poli, Antoine / Ged, Cecile / Schmitt, Caroline / Lefebvre, Thibaud / Manceau, Hana / Daher, Raêd / Moulouel, Boualem / Peoc'h, Katell / Simonin, Sylvie / Blouin, Jean-Marc / Deybach, Jean-Charles / Nicolas, Gaël / Puy, Hervé / Richard, Emmanuel / Gouya, Laurent

    Haematologica

    2021  Volume 106, Issue 3, Page(s) 913–917

    MeSH term(s) Humans ; Phlebotomy ; Porphyria, Erythropoietic/diagnosis ; Porphyria, Erythropoietic/therapy
    Language English
    Publishing date 2021-03-01
    Publishing country Italy
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 2333-4
    ISSN 1592-8721 ; 0017-6567 ; 0390-6078
    ISSN (online) 1592-8721
    ISSN 0017-6567 ; 0390-6078
    DOI 10.3324/haematol.2019.228270
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top